Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

Lentz, S.R. (57209010337)S.R. (57209010337)LentzCerqueira, M. (56950129600)M. (56950129600)CerqueiraJanic, D. (15729368500)D. (15729368500)JanicKempton, C. (8983076800)C. (8983076800)KemptonMatytsina, I. (15081291500)I. (15081291500)MatytsinaMisgav, M. (6602347931)M. (6602347931)MisgavOldenburg, J. (7005152976)J. (7005152976)OldenburgOzelo, M. (6603097867)M. (6603097867)OzeloRecht, M. (35269783400)M. (35269783400)RechtRosholm, A. (6508361050)A. (6508361050)RosholmSavic, A. (19537112200)A. (19537112200)SavicSuzuki, T. (58880979600)T. (58880979600)SuzukiTiede, A. (14720292000)A. (14720292000)TiedeSantagostino, E. (7004132887)E. (7004132887)Santagostino2025-06-122025-06-122016https://doi.org/10.1111/hae.12990https://www.scopus.com/inward/record.uri?eid=2-s2.0-84990184702&doi=10.1111%2fhae.12990&partnerID=40&md5=096b0a9edaec4b610ede44bebf29ee4chttps://remedy.med.bg.ac.rs/handle/123456789/7466[No abstract available]Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A